ADAM	a disintegrin and metalloprotease
ADCC	antibody-dependent cellular cytotoxicity
ALL	acute lymphoblastic leukemia
AML	acute myeloid leukemia
AMP	adenosine monophosphate
BM	bone marrow
BMSC	bone marrow stromal cells
CAFs	carcinoma-associated fibroblasts
CAR	chimeric antigen receptor
CDC	complement-dependent cytotoxicity
CLIR	C-lectin type inhibitory receptors
CLL	chronic lymphocytic leukemia
CML	chronic myelogenous leukemia
CTL	cytolytic T lymphocytes
CTLA-4	cytotoxic T lymphocyte antigen 4
DC	dendritic cell
DNAM-1	DNAX accessory molecule 1
ECM	extracellular matrix component
EMT	epithelial–mesenchymal transition
EGF	epidermal growth factor
EGFR	epidermal growth factor receptor
FAP	fibroblast activation protein
PGE2	prostaglandin E2
HSC	hematopoietic stem cells
Her2b	epidermal growth receptor 2b
HGF	hepatocyte growth factor
HL	Hodgkin lymphoma
HLA	human class I leukocyte antigen
KIR	killer Ig-like inhibitory receptor
IDO	indoleamine 2,3, deoxigenase
IFNγ	interferon γ
IL	inteleukin-2, 6, 10, 12, 15, 18
LILRB	leukocyte immunoglobulin-like receptors
LNMSC	lymph node MSC
MDSC	myeloid-derived suppressor cells
MICA/B	MHC class I polypeptide related sequence A/B
MM	multiple myeloma
MMP	membrane metalloprotease
MSC	mesenchymal stromal cells
NCR	natural cytotoxicity receptor
NHL	non-Hodgkin lymphoma
NK cell	natural killer cell
NKG2D	natural-killer group 2 member D
NKG2DL	NKG2D ligand
NKT	natural killer-like T cells
N-BPs	aminobisphosphonates
PD1	programmed death-1
PDL1	programmed death ligand-1
P4H	prolyl-4-idroxilase
SCID	severe combined immunodeficiency
SDF-1	stromal-derived factor 1
SMA	smooth muscle actin
TAA	tumor-associated antigen
TACE	tumor necrosis factor-α-converting enzyme
TAF	tumor-associated fibroblasts
TIGIT	T cell immunoglobulin and ITIM domain
TGFβ	transforming growth factor β
TNFα	tumor necrosis factor α
Treg	regulatory T cells
ULBP1-6	UL16 binding protein 1–6